We use analytics cookies to give us insight into how our website is being used. Learn more in our cookie notice I Accept +
Bleepa achieves CE Mark - Raising the bar for medical communication platforms

+44 (0) 20 3997 7634 | sales@fbkmed.com

Selection of patients with advanced non-small cell lung cancer for chemotherapy: Potential cost-effectiveness of CT texture analysis.

Selection of patients with advanced non-small cell lung cancer for chemotherapy: Potential cost-effectiveness of CT texture analysis.

05/03/12
Back To News +

Latest Articles

Year end trading update

16/06/22

Bleepa Cadran Feedback Medical Feedback PLC

Bleepa wins two NHS contract awards

12/04/22

Bleepa Feedback Medical Feedback PLC

Bleepa TB screening pilot now live in Odisha

31/03/22

Bleepa Feedback Medical Feedback PLC